Rios Israel 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Apr 4, 2012
Insider Transaction Report
Form 4
Rios Israel
Chief Medical Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2012-03-15+60,000→ 60,000 totalExercise: $6.22Exp: 2022-03-15→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.